IDEAYA Biosciences, Inc. - Common Stock (IDYA) stock analysis

IDYA · IDEAYA Biosciences, Inc. - Common Stock

Latest recorded price: USD 30.36

Sector and industry: Healthcare · Biotechnology

Fiscal 2025 figures: revenue growth 62.5%, free cash flow margin -33.6%, ROIC -68.3%. The model flags 2 risk signals for this company (1 high severity).

Similar companies in Healthcare